Antivenoms needed, say officials, but companies won't bite [PDF]
Stu Hutson
openalex +1 more source
Antivenoms: potency or median effective dose, which to use? [PDF]
Víctor Morais+3 more
openalex +1 more source
A Controlled Clinical Trial of A Novel Antivenom in Patients Envenomed by Bungarus multicinctus [PDF]
Ha Tran Hung+3 more
openalex +1 more source
Retrospective analysis of clinical and epidemiological characteristics of Chinese cobra bites in a South China emergency department. [PDF]
Huang Z+6 more
europepmc +1 more source
Cross-neutralization of the coagulant activity of Crotalus durissus terrificus venom from the northeast of Argentina by bivalent bothropic antivenom [PDF]
Juan Pablo Rodríguez+5 more
openalex +1 more source
Snakebite on the hand: Lessons from two clinical cases illustrating difficulties of Surgical Indication [PDF]
Gras, S
core +1 more source
The frequency, clinical characteristics and outcomes of Naja species related injuries in Malaysia consulted to Remote Envenomation Consultancy Services from 2020-2023. [PDF]
Ismail AK+4 more
europepmc +1 more source
Long-Term Clinical Outcomes of Rattlesnake Envenomation in Arizona Following Treatment With Crofab vs Anavip: A Retrospective Observational Study. [PDF]
Smelski GT+5 more
europepmc +1 more source
354 Clinical Effects and Antivenom Use for Snake Bite Victims Treated at Three US Hospitals in Afghanistan [PDF]
Jason D. Heiner+4 more
openalex +1 more source
Challenges and management of venomous bites and scorpion stings in Lebanon: a qualitative study. [PDF]
Kadi K+7 more
europepmc +1 more source